S&P 500   4,559.75 (-0.38%)
DOW   34,601.39 (-0.11%)
QQQ   385.24 (-1.20%)
AAPL   162.77 (-0.60%)
MSFT   326.29 (-0.97%)
FB   306.23 (-1.34%)
GOOGL   2,857.01 (-0.08%)
AMZN   3,411.33 (-0.76%)
TSLA   1,047.52 (-3.42%)
NVDA   308.61 (-3.94%)
BABA   111.30 (-8.77%)
NIO   32.70 (-9.67%)
CGC   9.87 (-4.73%)
AMD   146.00 (-3.11%)
GE   94.08 (-1.21%)
MU   82.56 (-0.39%)
T   23.06 (+0.04%)
F   19.62 (-1.26%)
DIS   146.00 (-0.82%)
PFE   53.18 (+0.26%)
AMC   28.91 (-4.52%)
ACB   5.92 (-3.58%)
BA   196.99 (-2.66%)
S&P 500   4,559.75 (-0.38%)
DOW   34,601.39 (-0.11%)
QQQ   385.24 (-1.20%)
AAPL   162.77 (-0.60%)
MSFT   326.29 (-0.97%)
FB   306.23 (-1.34%)
GOOGL   2,857.01 (-0.08%)
AMZN   3,411.33 (-0.76%)
TSLA   1,047.52 (-3.42%)
NVDA   308.61 (-3.94%)
BABA   111.30 (-8.77%)
NIO   32.70 (-9.67%)
CGC   9.87 (-4.73%)
AMD   146.00 (-3.11%)
GE   94.08 (-1.21%)
MU   82.56 (-0.39%)
T   23.06 (+0.04%)
F   19.62 (-1.26%)
DIS   146.00 (-0.82%)
PFE   53.18 (+0.26%)
AMC   28.91 (-4.52%)
ACB   5.92 (-3.58%)
BA   196.99 (-2.66%)
S&P 500   4,559.75 (-0.38%)
DOW   34,601.39 (-0.11%)
QQQ   385.24 (-1.20%)
AAPL   162.77 (-0.60%)
MSFT   326.29 (-0.97%)
FB   306.23 (-1.34%)
GOOGL   2,857.01 (-0.08%)
AMZN   3,411.33 (-0.76%)
TSLA   1,047.52 (-3.42%)
NVDA   308.61 (-3.94%)
BABA   111.30 (-8.77%)
NIO   32.70 (-9.67%)
CGC   9.87 (-4.73%)
AMD   146.00 (-3.11%)
GE   94.08 (-1.21%)
MU   82.56 (-0.39%)
T   23.06 (+0.04%)
F   19.62 (-1.26%)
DIS   146.00 (-0.82%)
PFE   53.18 (+0.26%)
AMC   28.91 (-4.52%)
ACB   5.92 (-3.58%)
BA   196.99 (-2.66%)
S&P 500   4,559.75 (-0.38%)
DOW   34,601.39 (-0.11%)
QQQ   385.24 (-1.20%)
AAPL   162.77 (-0.60%)
MSFT   326.29 (-0.97%)
FB   306.23 (-1.34%)
GOOGL   2,857.01 (-0.08%)
AMZN   3,411.33 (-0.76%)
TSLA   1,047.52 (-3.42%)
NVDA   308.61 (-3.94%)
BABA   111.30 (-8.77%)
NIO   32.70 (-9.67%)
CGC   9.87 (-4.73%)
AMD   146.00 (-3.11%)
GE   94.08 (-1.21%)
MU   82.56 (-0.39%)
T   23.06 (+0.04%)
F   19.62 (-1.26%)
DIS   146.00 (-0.82%)
PFE   53.18 (+0.26%)
AMC   28.91 (-4.52%)
ACB   5.92 (-3.58%)
BA   196.99 (-2.66%)
NASDAQ:TARS

Tarsus Pharmaceuticals SEC Filings & 10K Form

$25.81
-0.19 (-0.73%)
(As of 12/3/2021 12:00 AM ET)
Add
Compare
Today's Range
$25.18
$25.85
50-Day Range
$21.21
$29.68
52-Week Range
$21.00
$63.69
Volume
8 shs
Average Volume
44,478 shs
Market Capitalization
$533.67 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A

Tarsus Pharmaceuticals (NASDAQ:TARS) SEC Filings

DateFilerForm TypeView
09/03/2021
5:53 PM
Ackermann Michael (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2021
4:51 PM
Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2021
6:28 PM
Crane Rosemary A (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2021
6:23 PM
Crane Rosemary A (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/12/2021
3:01 PM
Tarsus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2021
8:30 PM
Tarsus Pharmaceuticals (Issuer)
Vivo Capital Fund IX, L.P. (Reporting)
Vivo Capital IX, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2021
7:51 PM
Tarsus Pharmaceuticals (Issuer)
Vivo Capital Fund IX, L.P. (Reporting)
Vivo Capital IX, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2021
6:28 PM
Tarsus Pharmaceuticals (Issuer)
YARNO WENDY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2021
6:26 PM
Tarsus Pharmaceuticals (Issuer)
Tester Jason E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2021
6:25 PM
LINK WILLIAM J PHD (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2021
6:21 PM
Goldberg Andrew D. (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2021
6:20 PM
CHAUDHURI BHASKAR (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2021
6:19 PM
Ackermann Michael (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2021
7:01 PM
RTW INVESTMENTS, LP (Reporting)
Tarsus Pharmaceuticals (Issuer)
WONG RODERICK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2021
8:07 PM
Tarsus Pharmaceuticals (Issuer)
Vivo Capital Fund IX, L.P. (Reporting)
Vivo Capital Fund IX, L.P. (Reporting)
Vivo Capital IX, LLC (Reporting)
Vivo Capital IX, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2021
8:07 PM
Tarsus Pharmaceuticals (Issuer)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2021
5:07 AM
Tarsus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2021
4:20 PM
Tarsus Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/04/2021
7:14 PM
Holdbrook Mark J. (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
3:37 PM
FLYING L INVESTMENTS XI, LLC (Filed by)
Tarsus Pharmaceuticals (Subject)
Form SC 13G
02/16/2021
2:46 PM
PERCEPTIVE ADVISORS LLC (Filed by)
Tarsus Pharmaceuticals (Subject)
Form SC 13G
02/16/2021
2:34 PM
Cormorant Asset Management, LP (Filed by)
Tarsus Pharmaceuticals (Subject)
Form SC 13G/A
02/12/2021
4:19 PM
Ackermann Michael (Filed by)
Tarsus Pharmaceuticals (Subject)
Form SC 13G
02/12/2021
8:42 AM
RTW INVESTMENTS, LP (Filed by)
Tarsus Pharmaceuticals (Subject)
Form SC 13G/A
02/02/2021
6:57 PM
Tarsus Pharmaceuticals (Issuer)
Wahl Bryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2021
12:24 PM
Tarsus Pharmaceuticals (Issuer)
Wahl Bryan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/08/2021
3:57 PM
Neervannan Seshadri (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2021
3:55 PM
Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2021
3:53 PM
Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2021
3:49 PM
Tarsus Pharmaceuticals (Issuer)
Whitfield Dianne C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2021
3:46 PM
Tarsus Pharmaceuticals (Issuer)
Whitfield Dianne C. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/24/2020
8:27 PM
Tarsus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/23/2020
6:00 PM
Tarsus Pharmaceuticals (Issuer)
YARNO WENDY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/23/2020
5:58 PM
Tarsus Pharmaceuticals (Issuer)
YARNO WENDY L (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/17/2020
7:33 AM
Tarsus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2020
4:00 PM
Horowitz Limited Partnership VIII (Filed by)
Tarsus Pharmaceuticals (Subject)
Form SC 13D
10/30/2020
3:00 PM
Cormorant Asset Management, LP (Filed by)
Tarsus Pharmaceuticals (Subject)
Form SC 13G
10/28/2020
3:31 PM
Tarsus Pharmaceuticals (Subject)
Vivo Capital IX, LLC (Filed by)
Form SC 13G
10/26/2020
1:39 PM
RTW INVESTMENTS, LP (Reporting)
Tarsus Pharmaceuticals (Issuer)
WONG RODERICK (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/26/2020
1:16 PM
RTW INVESTMENTS, LP (Filed by)
Tarsus Pharmaceuticals (Subject)
Form SC 13G
10/23/2020
12:40 PM
Frazier Life Sciences IX, L.P. (Filed by)
Tarsus Pharmaceuticals (Subject)
Form SC 13G
10/20/2020
7:01 PM
FHMLS IX, L.L.C. (Reporting)
FHMLS IX, L.P. (Reporting)
Frazier Life Sciences IX, L.P. (Reporting)
Heron Patrick J (Reporting)
Tarsus Pharmaceuticals (Issuer)
Topper James N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/20/2020
6:59 PM
Horowitz Limited Partnership VIII (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/20/2020
6:58 PM
Tarsus Pharmaceuticals (Issuer)
Vivo Capital Fund IX, L.P. (Reporting)
Vivo Capital IX, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/20/2020
6:57 PM
LINK WILLIAM J PHD (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/20/2020
6:56 PM
Tarsus Pharmaceuticals (Issuer)
Tester Jason E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/20/2020
6:54 PM
Ackermann Michael (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/20/2020
6:53 PM
Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/20/2020
4:09 PM
Tarsus Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
10/20/2020
3:36 PM
Tarsus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2020
3:40 PM
Tarsus Pharmaceuticals (Filer)
Form 424B4
10/15/2020
11:15 PM
Tarsus Pharmaceuticals (Filer)
Form EFFECT
10/15/2020
8:17 PM
Tarsus Pharmaceuticals (Filer)
Form S-1MEF
10/15/2020
7:27 PM
FHMLS IX, L.L.C. (Reporting)
FHMLS IX, L.P. (Reporting)
Frazier Life Sciences IX, L.P. (Reporting)
Heron Patrick J (Reporting)
Tarsus Pharmaceuticals (Issuer)
Topper James N (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/15/2020
7:26 PM
Horowitz Limited Partnership VIII (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/15/2020
7:24 PM
Tarsus Pharmaceuticals (Issuer)
Vivo Capital Fund IX, L.P. (Reporting)
Vivo Capital IX, LLC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/15/2020
7:23 PM
LINK WILLIAM J PHD (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/15/2020
7:22 PM
Tarsus Pharmaceuticals (Issuer)
Tester Jason E. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/15/2020
7:20 PM
CHAUDHURI BHASKAR (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/15/2020
7:18 PM
Goldberg Andrew D. (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/15/2020
7:16 PM
Ackermann Michael (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/15/2020
7:14 PM
Holdbrook Mark J. (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/15/2020
7:13 PM
Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/15/2020
7:11 PM
Neervannan Seshadri (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/15/2020
7:08 PM
Greenstein Leonard M. (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/15/2020
7:07 PM
Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/15/2020
9:33 AM
Tarsus Pharmaceuticals (Filer)
Form CERT
10/09/2020
6:31 PM
Tarsus Pharmaceuticals (Filer)
Form 8-A12B
10/09/2020
6:31 PM
Tarsus Pharmaceuticals (Filer)
Form 8-A12B
10/09/2020
4:16 PM
Tarsus Pharmaceuticals (Filer)
Form S-1/A
09/25/2020
4:25 PM
Tarsus Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
This page was last updated on 12/3/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.